Determination of Dabigatran in Dog Plasma by LC-MS/MS and Its Application to a Pharmacokinetic Study of Dabigatran Etexilate Nanosuspension

Shuangchen Cong,Yuanyuan Zhang,Jiongxi Lei,Maoyuan Song,Wenxi Zhang,Guanghua Peng,Mengya Yin,Jiajia Li,Jiaxing Wang,Xinru Li
DOI: https://doi.org/10.5246/jcps.2017.08.066
2017-01-01
Journal of Chinese Pharmaceutical Sciences
Abstract:In this study,a sensitive and rapid LC-MS/MS method was developed and validated to determine dabigatran in plasma of beagle dogs after oral administration of dabigatran etexilate nanosuspension (DABE-NS).The analytes (dabigatran) and sertraline hydrochloride (internal standard,IS) were separated on a Kromasil C18 column using gradient elution consisting of methanol and formate buffer at a flow rate of 0.4 mL/min in 20 min.Detection and quantitation were carried out by multiple reaction monitoring following the transitions:m/z 472.17→289.07 and 305.98,275.00 for dabigatran and IS at positive ion mode,respectively.The calibration curves were linear from 1.0 to 500.0 ng/mL for dabigatran with r =0.9995.The accuracy of each analyte ranged from 94.8% to 107.1%,and the precision was within 6%.Besides,this method was successfully applied in the investigation of the pharmacokinetic profile of dabigatran in beagle dogs after oral administration of DABE-NS.The maximum concentration and the areas under curves of dabigatran for DABE-NS were significantly higher than those of control formulation,indicating improved oral absorption.
What problem does this paper attempt to address?